Related Experiment Videos

Noncardiogenic pulmonary edema following injection of methotrexate into the cerebrospinal fluid

Cancer
|September 1, 1982
PubMed

Insights

Methotrexate can cause lung injury. Rapid respiratory distress after intrathecal methotrexate suggests noncardiogenic pulmonary edema, a rare but serious side effect.

Area of Science:

  • Pulmonology
  • Oncology
  • Pharmacology

Background:

  • Methotrexate is a common chemotherapy agent.
  • Methotrexate-induced lung disease (MILD) typically presents as interstitial pneumonitis.
  • MILD usually develops gradually after oral or intravenous administration.

Observation:

  • A rare case of MILD following intrathecal methotrexate was previously reported.
  • We present two cases of acute respiratory distress after intrathecal methotrexate.
  • Clinical and pathological findings suggest noncardiogenic pulmonary edema.

Findings:

  • Intrathecal methotrexate can cause rapidly progressing respiratory distress.
  • This presentation is consistent with noncardiogenic pulmonary edema.
  • Pathologic findings in one patient confirmed pulmonary edema.

Implications:

  • Clinicians should consider noncardiogenic pulmonary edema in patients with respiratory distress after intrathecal methotrexate.
  • Early recognition and management are crucial for improving patient outcomes.
  • This highlights a potentially severe adverse effect of intrathecal methotrexate administration.

Related Concept Videos